---
Awakn in the Media

Awakn in the Media

Asset-15

ITV News - How psychedelic-assisted psychotherapy has the potential to revolutionize the treatment of Addiction & other MentalHealth conditions

Asset-12

The Times - Can Ketamine help cure alcoholism

Asset-17

The Evening Standard - Inside London’s first psychedelic psychotherapy clinic

Asset-13

ABC - How Awakn’s psychedelic-assisted psychotherapy research has the potential to help patients with Addictions and Mental illness to overcome trauma.

Asset-14

Vice - The future of medicine will be drugs you never heard of

Asset-11

Forbes - Ketamine to treat gambling addiction - Anthony Tennyson

Asset-10

Business Insider - Scientists say ketamine could help people quit alcohol after 'encouraging' study

Asset-1

Psychedelic spotlight - the 5 most influential psychedelic studies in the world

Asset-9

Triggernometry - Prof. David Nutt - The truth about drugs 

Asset-8

Medscape - Ketamine an intriguing new therapy for alcoholics

Asset-7

The Naked scientists - Prof Nutt - What psychedelics do to your brain 

Asset-6

Pharmacy Times - Prof Celia Morgan - The future of Ketamine-assisted therapy

Asset-3

Technology Networks - Anthony Tennyson and Prof. David Nutt - Treating addiction with Psychedelics

Asset-4

New Atlas - Highlighting groundbreaking studies in psychedelics

Asset-5

The Dales Report -  A new hope for Alcoholics

Asset-2

Free think media - Ketamine therapy may help drinkers stay abstinent

Videos and Podcasts

Asset-20

Ketamine for Depression - Video presentation, Santa Fe, NM

Asset-21

Ketamine for Substance Use Disorders - Video presentation, Nordic Reform Conference

Asset-18

LOWAN H STEWART: PSYCHEDELICS, A GAME CHANGER IN MENTAL HEALTH - Podcast, Hennings Verden

Asset-19

Medtalk Podcast - Prof. David Nutt

General coverage of the industry

Asset-28

New York Times - Can we stop suicides?

Asset-24

Time - New hope for depression

Asset-26

Bloomberg Business Week - Is ketamine the best hope for curing major depression

Asset-27

Web MD - Ketamine for Depression

Asset-25

Scientific American - Rave Drug "Special K" Holds Promise for Treating Depression Fast

Asset-27

Web MD - Ketamine: The Future of Depression Treatment

Asset-23

Nautilus - A Vaccine for Depression: Ketamine's remarkable effect bolsters a new theory of mental illness

Sign Up for Newsletter

Awakn Clinics London  
18 Dukes Road, WC1H 9PY, London, United Kingdom
Phone: +44 207 387 2596
london@awaknclinics.com

Awakn Clinics Oslo  
Bogstadveien 11, 0355 Oslo, Inngang fra Sporveisgata i 3. etasje.
Phone: +47 214 038 19
oslo@awaknclinics.com

Awakn Clinics Trondheim
Nordre gate 11, 7011 Trondheim
trondheim@awaknclinics.com
Telefon: +47 45 85 57 47

© 2023 Awakn Life Sciences Corp    |    Cookie Policy       Terms and Conditions    |   Privacy Policy   |   Terms of Service

Back to top Arrow